Jean-Pierre Bizzari
Director, Celator Pharmaceuticals Inc.
Companies
- ADC Therapeutics SABoard member Jan 2, 2024 to now1
- Aprea Therapeutics, Inc.Board member Aug 24, 2023 to now2
- Halozyme TherapeuticsBoard member Jan 21, 2015 to May 9, 20233
- PALVELLA THERAPEUTICS, INC.Board member Jun 29, 2015 to Jan 28, 20204
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Halozyme Therapeutics HALO66,815 shares5$8.2M at $122.96May 5, 2023
- ADC Therapeutics SA ADCT139,302 shares6$205.4K at $1.47Jun 3, 2026
- Aprea Therapeutics, Inc. APRE4,180 shares7$2.4K at $0.56Jun 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 16, 2026Granted 3,135 shares of Aprea Therapeutics, Inc.7
- Jun 3, 2026Shares withheld for tax 12,600 shares at $3.08 of ADC Therapeutics SA6
- Jun 1, 2026Granted 45,000 shares of ADC Therapeutics SA6
- Jun 13, 2025Shares withheld for tax 12,600 shares at $3.58 of ADC Therapeutics SA8
- Jun 5, 2025Granted 1,045 shares of Aprea Therapeutics, Inc.9
- Jun 3, 2025Granted 40,000 shares of ADC Therapeutics SA10
- Jun 17, 2024Sold 6,995 shares at $2.89 of ADC Therapeutics SA11
- Jun 13, 2024Granted 40,000 shares of ADC Therapeutics SA12
- May 5, 2023Granted 8,065 shares of Halozyme Therapeutics5
- May 5, 2022Granted 6,206 shares of Halozyme Therapeutics13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARADC Therapeutics SA, Board member
- 2
- 3SEC EDGARHalozyme Therapeutics, Board member
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Jun 17, 2025
- 9SEC EDGARForm 4 filed Jun 9, 2025
- 10SEC EDGARForm 4 filed Jun 5, 2025
- 11SEC EDGARForm 4 filed Jun 18, 2024
- 12SEC EDGARForm 4 filed Jun 14, 2024
- 13SEC EDGARForm 4 filed May 6, 2022